Global Defibrillator Market Review 2011-2019 and Forecast to 2025 - High Incidences of Sudden Cardiac Arrest (SCA) and Cardiovascular Diseases (CVD) to Drive the MarketHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Defibrillator Market Review 2011-2019 and Forecast to 2025 - High Incidences of Sudden Cardiac Arrest (SCA) and Cardiovascular Diseases (CVD) to Drive the MarketGlobeNewswireJanuary 2, 2020ReblogShareTweetShareDublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Defibrillator Market Global Forecast, by Product [Implantable Cardioverter Defibrillator, Automated External Defibrillators], End Users, Regions, Companies" report has been added to ResearchAndMarkets.com's offering.The Global Defibrillator Market is likely to surpass the US$ 15 Billion mark by the end of 2025.Rising incidence of cardiovascular disease due to eating habits and changing lifestyles will greatly impact the global defibrillator market in the long run. A defibrillator is a life saving apparatus that maintains the rhythm of the heart no matter the heartbeat fast or slow. In the current scenario, companies are pouring the fund in research and development programs to design an innovative product to ensure the safety of life. The major factors that influence the market growth are; increasing incidence of cardiovascular disease, an increasing number of cardiac arrest globally, advancement in technology, increasing research & development towards Defibrillator technology, increasing number of innovative products, increasing geriatric population across the world, greater significance and role of the machine in saving life etc. Moreover, various types of defibrillator machines getting quick approval will further boost the market in the forecast period.Product Insight - Implantable Cardioverter Defibrillator will Dominate the Global MarketIn this report, the researchers have done comprehensive analysis of global Defibrillator market by products: [Implantable Cardioverter Defibrillator {Transvenous Implantable Cardioverter Defibrillators (Single-chamber ICDs & Dual-chamber ICDs & Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators) & Subcutaneous Implantable Cardioverter Defibrillators}, Automated External Defibrillators, Advanced Life Support Defibrillators and Wearable Cardioverter Defibrillators]. End-users Insight - High Demand of Defibrillator in Hospital In this report, the researchers have fragmented the market on the basis of end-users into 4 parts; Hospital, Pre-hospital, Public Access Market, Alternate Care Market, and Home Healthcare. In addition, the researchers have analyzed the key factors that influence the market of the small segments like the Alternate Care Market and Home HealthcareRegional Insight - Asia-Pacific will be the Fastest Growing Market in Global Defibrillator MarketIn this report, the publisher has provided a 360-degree perspective on the regional market along with key factors and key challenges that will impact the market in the long run. According to this analysis, the Asia-Pacific would be the fastest-growing region in the global market. Here the market is categorized into 5 regional markets; North America, Latin America, Europe, Asia-Pacific, Middle East/Africa (MEA)Major Key Players InsightIn this report, the publisher has done complete insight on the competitive landscape like top key players analysis that will impact the global defibrillator market; Boston Scientific, Medtronic, Philips Healthcare, Nihon Kohden Corporation, St. Jude Medical, and ZOLL Medical Corporation (acquired by Asahi Kasei Corporation).All six companies have been studied from two points:Company OverviewFinancial InsightKey Topics Covered 1. Executive Summary2. Global Defibrillator Market3. Market Share - Global Defibrillator (2011-2024)3.1 By Product3.2 By Region4. By Product - Global Defibrillator Market (2011-2024)4.1 Implantable Cardioverter Defibrillator4.1.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)4.1.1.1 Single-chamber ICDs4.1.1.2 Dual-chamber ICDs4.1.1.3 Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)4.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)4.2 Automated External Defibrillators4.3 Advanced Life Support Defibrillators4.4 Wearable Cardioverter Defibrillators5. By End User - Global Defibrillator Market (2011-2024)5.1 Hospitals5.2 Pre-Hospitals5.3 Public Access Market5.4 Alternate Care Market5.5 Home Healthcare6. By Region - Global Defibrillator Market (2011-2024)7. Company Analysis7.1 Medtronic7.2 Boston Scientific7.3 Philips Healthcare7.4 St. Jude Medical7.5 Nihon Kohden Corporation7.6 Zoll Medical8. Growth Drivers8.1 High incidences of Sudden Cardiac Arrest (SCA) and Cardiovascular Diseases (CVD)8.2 Rapidly Growing Geriatric Population with Elevated Risk of Targeted Diseases9. Key Challenges9.1 Lack of Awareness about Sudden Cardiac Arrest (SCA)
For more information about this report visit https://www.researchandmarkets.com/r/d7xbg6Story continuesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextDow Jones sinks due to fears over coronavirus outbreakPA Media: World NewsFear Seen All Over Canada Market Hit By Virus, Economy ChillBloombergWhat You Must Know About Thor Explorations Ltd.'s (CVE:THX) Beta ValueSimply Wall St.One Thing To Remember About The True North Gems Inc. (CVE:TGX) Share PriceSimply Wall St.Beyond Meat, Best Buy earnings: What to know in markets ThursdayYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo Finance